Azur Pharma is dedicated to enhancing patient's lives by developing and marketing pharmaceutical products in focused therapeutic areas. Its mission is to create a therapeutically focused pharmaceutical business, sustained through a marketed product portfolio and a product pipeline. Azur Pharma's strategy is to identify, evaluate, selectively acquire and enhance the value of FDA approved, and late-stage development, pharmaceutical assets. In June 2005, Azur Pharma completed a private placement of equity securities in an amount of EUR40 million (US$50 million).